EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bioflavonoid Daidzein: Therapeutic Insights, Formulation Advances, and Future Directions

Sana Ahmad, Farogh Ahsan, Javed Akhtar Ansari, Tarique Mahmood, Shahzadi Bano, Mo Shahanawaz

Drug Research · 01.11.2024 · 74 (09) · 433-455

DOI: 10.1055/a-2379-6849 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Research, erschienen am 01.11.2024. Verfasst von Sana Ahmad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Integral University, Dasauli, Kursi road, Lucknow (U.P.)-India. Hauptthemen laut MEDLINE: Isoflavones, Biological Availability. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 89 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bioflavonoids, are a diverse group of phytonutrients that are widely distributed in fruits, vegetables, grains, teas, and certain medicinal herbs. They are characterized by their antioxidant properties and play essential roles in plant biology, such as providing color to fruits and flowers, protecting plants from environmental stresses. Daidzein, a bioflavonoid classified under natural products, is sourced from plants like soybeans and legumes. It exists in forms such as glycosides and aglycones, with equol and trihydroxy isoflavone being key metabolites formed by gut bacteria. Known for its wide-ranging therapeutic potential, daidzein has shown effects on cardiovascular health, cancer, diabetes, skin conditions, osteoporosis, and neurodegenerative disorders. Its mechanisms include interaction with estrogen receptors, antioxidative and anti-inflammatory properties, and modulation of apoptosis and cell cycles. Recent advances in formulation technologies aimed at enhancing daidzeinʼs bioavailability and efficacy are critically evaluated, including nanoparticle-based delivery systems and encapsulation strategies. Researchers have developed advanced formulations like nanoparticles and liposomes to enhance daidzeinʼs solubility, stability, bioavailability, and targeted delivery. Considered a promising nutraceutical, daidzein warrants further exploration into its molecular actions and safety profile to fully realize its clinical potential. This review offers a succinct overview encompassing therapeutic benefits, chemical characteristics, historical uses, toxicology insights, recent advancements in delivery systems, and future directions for daidzein research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoflavonesBiological AvailabilityHumansAnimalsDrug CompoundingDrug Delivery SystemsNanoparticlesDietary SupplementsAntioxidants

Substanzen

IsoflavonesdaidzeinAntioxidants

Autor:innen und Institutionen

  • Department of Pharmacy, Integral University, Dasauli, Kursi road, Lucknow (U.P.)-India.
  • Department of Chemistry, Integral University, Dasauli, Kursi road, Lucknow (U.P.)-India.

Zitieren

APA

Ahmad, S., Ahsan, F., Ansari, J. A., Mahmood, T., Bano, S., & Shahanawaz, M. (2024). Bioflavonoid Daidzein: Therapeutic Insights, Formulation Advances, and Future Directions. Drug Research, 74(09), 433-455. https://doi.org/10.1055/a-2379-6849

Vancouver

Ahmad S, Ahsan F, Ansari JA, Mahmood T, Bano S, Shahanawaz M. Bioflavonoid Daidzein: Therapeutic Insights, Formulation Advances, and Future Directions. Drug Research. 2024;74(09):433-455. doi:10.1055/a-2379-6849

BibTeX
@article{Ahmad2024,
  author = {Ahmad, Sana and Ahsan, Farogh and Ansari, Javed Akhtar and Mahmood, Tarique and Bano, Shahzadi and Shahanawaz, Mo},
  title = {Bioflavonoid Daidzein: Therapeutic Insights, Formulation Advances, and Future Directions},
  journal = {Drug Research},
  year = {2024},
  volume = {74},
  number = {09},
  pages = {433--455},
  doi = {10.1055/a-2379-6849}
}
Kostenlos starten →